DNA Found That Enables Growth of Wild-Type Hepatitis C Virus in Cell Cultures

Only the JFH-1 isolate has the capacity to replicate efficiently in cultured liver cells without first undergoing cell culture-adaptive mutations.

Investigators at The Rockefeller University (New York, NY, USA) hypothesized that cultured cells lack one or more factors required for the replication of clinical isolates. To identify these factors, the investigators used a pooled Lentivirus-based human complementary DNA (cDNA) library to transfect cultures of liver cancer cells with HCV subgenomic replicons lacking any adaptive mutations, and then selected for stable replicon colonies.

Results from screening more than 7,000 human genes by this process were published in the August 12, 2015, online edition of the journal Nature. They revealed the identification of a single cDNA, SEC14L2, which enabled RNA replication of diverse HCV genotypes in several liver cancer cell lines. This effect was dose-dependent and required the continuous presence of SEC14L2.

Remarkably, SEC14L2-expressing liver cancer cells also supported HCV replication following inoculation with patient sera. Mechanistic studies suggested, and the investigators speculated, that SEC14L2 promoted HCV infection by enhancing vitamin E-mediated protection against lipid peroxidation.

"Being able to easily culture HCV in the lab has many important implications for basic science research," said senior author Dr. Charles M. Rice, professor of virology at The Rockefeller University. "There is still much we do not understand about how the virus operates, and how it interacts with liver cells and the immune system."

Related Links:
The Rockefeller University